Zenith Drugs Limited (NSE:ZENITHDRUG)

Zenith Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	2.61	2.63	87.43	2.79	30.01
Cash & Short-Term Investments	2.61	2.63	87.43	2.79	30.01
Cash Growth	-0.72%	-96.99%	3032.53%	-90.70%	62.37%
Accounts Receivable	733.55	605.77	673.95	493.11	320.68
Other Receivables	-	-	-	-	0.68
Receivables	736.65	607.95	676.32	496.32	321.36
Inventory	424.22	396.12	257.58	236.73	121.31
Prepaid Expenses	-	-	-	-	3.37
Other Current Assets	126.16	118.07	107.02	103.38	59.25
Total Current Assets	1,290	1,125	1,128	839.22	535.3
Property, Plant & Equipment	468.8	431.86	148.42	116.98	131.23
Long-Term Investments	-	-	0.26	-	-
Other Intangible Assets	41.72	1.76	0.07	0.1	0.12
Long-Term Deferred Tax Assets	1.75	0.12	0.66	-	-
Other Long-Term Assets	73.29	56.26	23.76	0	19.2
Total Assets	1,875	1,615	1,342	979.25	685.85

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	555.89	401.84	426.31	508.74	346.81
Accrued Expenses	7.58	8.11	5.17	11.28	10.7
Short-Term Debt	244.99	301.92	140.06	157.89	40.57
Current Portion of Long-Term Debt	104.91	55.81	20.74	19.6	51.81
Current Income Taxes Payable	16.04	23.73	38.5	17.58	13.34
Other Current Liabilities	11.41	1.63	10.22	1.45	2.55
Total Current Liabilities	940.83	793.03	641	716.54	465.78
Long-Term Debt	201.15	127.96	78.53	83.63	95.71
Pension & Post-Retirement Benefits	-	-	-	-	0.67
Long-Term Deferred Tax Liabilities	-	-	-	1.72	2.63
Other Long-Term Liabilities	0	-0	-	-	-
Total Liabilities	1,142	920.98	719.53	801.89	564.79

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	171.49	171.49	171.49	4	4
Additional Paid-In Capital	306.58	306.58	306.58	2	2
Retained Earnings	255.15	215.72	144.11	171.22	114.91
Total Common Equity	733.22	693.79	622.19	177.22	120.91
Minority Interest	-	-	-	0.15	0.15
Shareholders' Equity	733.22	693.79	622.19	177.36	121.06
Total Liabilities & Equity	1,875	1,615	1,342	979.25	685.85

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	551.05	485.68	239.33	261.12	188.09
Net Cash (Debt)	-548.44	-483.05	-151.9	-258.33	-158.08
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-31.98	-28.17	-8.86	-21.53	-13.17
Filing Date Shares Outstanding	17.15	17.15	17.15	12	12
Total Common Shares Outstanding	17.15	17.15	17.15	12	12
Working Capital	348.81	331.75	487.35	122.68	69.52
Book Value Per Share	42.76	40.46	36.28	14.77	10.08
Tangible Book Value	691.5	692.03	622.11	177.12	120.79
Tangible Book Value Per Share	40.32	40.35	36.28	14.76	10.07
Land	33.27	33.27	33.27	-	27.47
Buildings	188.4	180.57	53.04	-	52.8
Machinery	326.93	305.94	112.34	-	87.45
Construction In Progress	98.18	31.02	39.07	-	26.62

Data Source: S&P Global Market Intelligence Last updated: Sep 8, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 3, 2026

Data Sources Report a data error